United States Biotechnology & Medical Research

Electra Therapeutics Inc (ETRA)

Electra Therapeutics Inc witnessed significant buying activity recently, with two insiders acquiring shares worth approximately 40 million dollars. These four transactions occurred on September 21, 2026, amid a 39.7 percent decline in stock value over the past quarter. No executive-level trades were recorded, and the company has not released a recent earnings report.
Ticker: ETRA
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Electra Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
74.88
Quantity 47,860 +18.8%
Value US$3,338,609
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
220.19
Quantity 58,098 -36.5%
Value US$4,351,254
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
83.04
Quantity 3,247 +30.0%
Value US$724,489
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.31
Quantity 1,000 +0.6%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.07
Quantity 1,000 +1.0%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.07
Quantity 1,000 +0.1%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.78
Quantity 1,000 +1.9%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.78
Quantity 1,000 +0.2%
Value US$100,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.07
Quantity 1,000 +1.0%
Value US$100,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.07
Quantity 1,000 +0.1%
Value US$100,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.78
Quantity 1,000 +1.9%
Value US$100,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.78
Quantity 1,000 +0.2%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.88
Quantity 1,000 +5.3%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.88
Quantity 1,000 +0.5%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.84
Quantity 1,000 +5.6%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.84
Quantity 1,000 +0.5%
Value US$100,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.88
Quantity 1,000 +5.3%
Value US$100,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.88
Quantity 1,000 +0.5%
Value US$100,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.84
Quantity 1,000 +5.6%
Value US$100,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.84
Quantity 1,000 +0.5%
Value US$100,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 1,000,000 +131.9%
Value US$15,000,000
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 333,333 +7.0%
Value US$4,999,995
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 1,000,000 +131.9%
Value US$15,000,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 333,333 +7.0%
Value US$4,999,995
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-05 2026-11-05 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
47,860 +18.8%
74.88
US$3,338,609 		47,860 +18.8% 74.88 US$3,338,609
2026-11-05 2026-11-05 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
58,098 -36.5%
220.19
US$4,351,254 		58,098 -36.5% 220.19 US$4,351,254
2026-11-05 2026-11-05 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
3,247 +30.0%
83.04
US$724,489 		3,247 +30.0% 83.04 US$724,489
2026-11-05 2026-11-05 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +0.6%
7.31
US$100,000 		1,000 +0.6% 7.31 US$100,000
2026-11-05 2026-11-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000 +1.0%
7.07
US$100,000 		1,000 +1.0% 7.07 US$100,000
2026-11-05 2026-11-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000 +0.1%
7.07
US$100,000 		1,000 +0.1% 7.07 US$100,000
2026-11-05 2026-11-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000 +1.9%
7.78
US$100,000 		1,000 +1.9% 7.78 US$100,000
2026-11-05 2026-11-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000 +0.2%
7.78
US$100,000 		1,000 +0.2% 7.78 US$100,000
2026-11-05 2026-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +1.0%
7.07
US$100,000 		1,000 +1.0% 7.07 US$100,000
2026-11-05 2026-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +0.1%
7.07
US$100,000 		1,000 +0.1% 7.07 US$100,000
2026-11-05 2026-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +1.9%
7.78
US$100,000 		1,000 +1.9% 7.78 US$100,000
2026-11-05 2026-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +0.2%
7.78
US$100,000 		1,000 +0.2% 7.78 US$100,000
2026-11-05 2026-11-03 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000 +5.3%
7.88
US$100,000 		1,000 +5.3% 7.88 US$100,000
2026-11-05 2026-11-03 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000 +0.5%
7.88
US$100,000 		1,000 +0.5% 7.88 US$100,000
2026-11-05 2026-11-03 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000 +5.6%
7.84
US$100,000 		1,000 +5.6% 7.84 US$100,000
2026-11-05 2026-11-03 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000 +0.5%
7.84
US$100,000 		1,000 +0.5% 7.84 US$100,000
2026-11-05 2026-11-03 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +5.3%
7.88
US$100,000 		1,000 +5.3% 7.88 US$100,000
2026-11-05 2026-11-03 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +0.5%
7.88
US$100,000 		1,000 +0.5% 7.88 US$100,000
2026-11-05 2026-11-03 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +5.6%
7.84
US$100,000 		1,000 +5.6% 7.84 US$100,000
2026-11-05 2026-11-03 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000 +0.5%
7.84
US$100,000 		1,000 +0.5% 7.84 US$100,000
2026-09-23 2026-09-21 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,000,000 +131.9%
15.00
US$15,000,000 		1,000,000 +131.9% 15.00 US$15,000,000
2026-09-23 2026-09-21 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
333,333 +7.0%
15.00
US$4,999,995 		333,333 +7.0% 15.00 US$4,999,995
2026-09-23 2026-09-21 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,000,000 +131.9%
15.00
US$15,000,000 		1,000,000 +131.9% 15.00 US$15,000,000
2026-09-23 2026-09-21 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
333,333 +7.0%
15.00
US$4,999,995 		333,333 +7.0% 15.00 US$4,999,995
Explore more

More insider trading research around Electra Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America